Spire Healthcare Group PLC 31.5% potential upside indicated by JP Morgan

Spire Healthcare Group PLC with ticker (LON:SPI) now has a potential upside of 31.5% according to JP Morgan.



JP Morgan set a target price of 341 GBX for the company, which when compared to the Spire Healthcare Group PLC share price of 234 GBX at opening today (20/09/2022) indicates a potential upside of 31.5%. Trading has ranged between 201 (52 week low) and 257 (52 week high) with an average of 662,468 shares exchanging hands daily. The market capitalisation at the time of writing is £912,406,251.

Spire Healthcare Group plc is a United Kingdom-based company that operates independent hospital group. The Company offer a range of treatments and services, such as Bones and joints, Cosmetic surgery, Eye surgery and treatments, Heart treatments, Men’s health, Urology, Weight loss, Women’s health, Back surgery, Breast enlargement, Cataract removal surgery, Gastric bypass surgery, Hip replacement surgery, Knee replacement, Prostate surgery, Cardiac computerized tomography (CT) scan, CT scan, Magnetic resonance imaging (MRI) scan, Ultrasound scan, X-ray, Bupa health and wellbeing plans, Spire General Practitioner (GP), Conditions and symptoms, Cataracts, Foot pain, Hip pain, Knee pain, Osteoarthritis, Rheumatoid arthritis, Sciatica and Spinal stenosis. It also provides wellness online tools and communities, Healthy lifestyle digital content, Virtual triage, eBooking services, Digital GP, ePrescribing, Direct to consumer testing, Chronic Disease Management and Digital care at home.